Financials Guardant Health, Inc.

Equities

GH

US40131M1099

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 17:03:10 15/01/2026 GMT			5-day change	1st Jan Change
110.37 ^USD	+1.63%		+1.77%	+8.35%

01-13	Guardant Health, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 03:45 PM
01-12	Guardant Health shares up 2.4% after preliminary Q4 revenue beats estimates	RE

Projected Income Statement: Guardant Health, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	286.7	373.7	449.5	563.9	739	969.1	1,232	1,571
Change	-	30.32%	20.31%	25.45%	31.04%	31.13%	27.13%	27.55%
EBITDA ¹	-85.18	-388.7	-498.9	-436.3	-399.5	-214.7	-155.9	15.02
Change	-	-356.34%	-28.34%	12.55%	8.42%	46.27%	27.39%	109.64%
EBIT ¹	-255	-411	-544.4	-564.7	-443.6	-404.5	-365.2	-255.8
Change	-	-61.21%	-32.45%	-3.74%	21.45%	8.82%	9.72%	29.95%
Interest Paid ¹	-4.766	-2.577	-2.577	-2.578	-2.581	-3.528	-3.297	-3.276
Earnings before Tax (EBT) ¹	-245.9	-384.5	-653.4	-478.8	-435.1	-380.7	-343.2	-232.4
Change	-	-56.35%	-69.96%	26.73%	9.12%	12.51%	9.85%	32.28%
Net income ¹	-253.8	-405.7	-654.6	-479.4	-436.4	-383.6	-346.6	-228
Change	-	-59.85%	-61.36%	26.76%	8.98%	12.09%	9.66%	34.23%
Announcement Date	24/02/21	23/02/22	23/02/23	22/02/24	20/02/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3
Net sales ¹	78.32	78.66	92.1	94.78	108.1	96.1	109.1	117.4	126.9	128.7	137.2	143	155.1	168.5	177.2	191.5	201.8	203.5	232.1	265.2	268.2	271.8	296.9	322.9	338.2	338.3	368.7	398.3
Change	-	0.45%	17.08%	2.91%	14.06%	-11.11%	13.57%	7.57%	8.08%	1.44%	6.55%	4.29%	8.41%	8.67%	5.19%	8.04%	5.4%	0.82%	14.06%	14.27%	1.15%	1.33%	9.23%	8.77%	4.72%	0.04%	8.98%	8.03%
EBITDA ¹	-29.8	-102.9	-92.02	-101.7	-92.12	-111.6	-120	-122.6	-133.3	-123.4	-108.1	-101.8	-102.9	-88.48	-89.58	-106.2	-115.3	-97.78	-95.49	-45.5	-51.75	-38.55	-32.56	-27.83	-29.66	4.3	13.1	28.7
Change	-	-245.13%	10.54%	-10.57%	9.46%	-21.11%	-7.57%	-2.18%	-8.68%	7.37%	12.39%	5.91%	-1.14%	14.03%	-1.25%	-18.55%	-8.53%	15.17%	2.34%	52.35%	-13.73%	25.51%	15.53%	14.53%	-6.57%	114.5%	204.65%	119.08%
EBIT ¹	-91.17	-107.9	-97.64	-107.3	-98.21	-123.3	-130.3	-144.6	-146.1	-134.1	-119.6	-113.5	-197.5	-99.68	-100.6	-117.3	-126	-111	-106.4	-98.99	-100.5	-95.61	-90.38	-80.63	-75.68	-81.34	-71.55	-55.22
Change	-	-18.31%	9.48%	-9.88%	8.46%	-25.59%	-5.66%	-10.96%	-1.05%	8.26%	10.77%	5.08%	-73.95%	49.53%	-0.94%	-16.61%	-7.36%	11.85%	4.17%	6.98%	-1.48%	4.83%	5.46%	10.79%	6.15%	-7.49%	12.04%	22.82%
Charge d'intérêts ¹	-4.736	-0.646	-0.644	-0.644	-0.643	-0.644	-0.645	-0.644	-0.644	-0.644	-0.645	-0.644	-0.645	-0.645	-0.645	-0.646	-0.645	-0.791	-0.983	-0.943	-0.9167	-0.84	-0.8667	-0.84	-0.8667	-0.9	-0.9	-0.9
Earnings before Tax (EBT) ¹	-92.78	-107.2	-97.49	-107.4	-72.3	-123.3	-229	-161.9	-139.3	-133.3	-72.28	-85.61	-187.6	-114.6	-102.5	-107.7	-110.3	-94.87	-99.86	-92.59	-94.67	-92.55	-85.33	-76.1	-72.62	-74.73	-65.63	-51.77
Change	-	-15.59%	9.1%	-10.19%	32.7%	-70.47%	-85.79%	29.31%	13.93%	4.33%	45.78%	-18.45%	-119.11%	38.92%	10.55%	-5.1%	-2.38%	13.98%	-5.26%	7.28%	-2.25%	2.25%	7.8%	10.82%	4.58%	-2.92%	12.18%	21.12%
Net income ¹	-93.74	-109.7	-97.58	-107.5	-90.91	-123.2	-229.4	-162	-139.9	-133.5	-72.77	-86.1	-187	-115	-102.6	-107.8	-111	-95.16	-99.9	-92.72	-96.79	-93.11	-88.49	-79.49	-75.15	-76.33	-65.72	-49.23
Change	-	-16.97%	11.02%	-10.2%	15.45%	-35.55%	-86.18%	29.39%	13.62%	4.57%	45.5%	-18.32%	-117.23%	38.52%	10.75%	-4.99%	-3.02%	14.28%	-4.98%	7.18%	-4.38%	3.8%	4.96%	10.17%	5.45%	-1.56%	13.9%	25.09%
Announcement Date	24/02/21	06/05/21	05/08/21	04/11/21	23/02/22	05/05/22	04/08/22	03/11/22	23/02/23	09/05/23	03/08/23	06/11/23	22/02/24	09/05/24	07/08/24	06/11/24	20/02/25	30/04/25	30/07/25	29/10/25	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Guardant Health, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	-989	202	126	-28.7	303	560	822	534
Change	-	120.42%	-37.62%	-122.78%	1,155.75%	85.08%	46.79%	-35.04%
Announcement Date	24/02/21	23/02/22	23/02/23	22/02/24	20/02/25	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Guardant Health, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	36.17	75.04	77.46	20.49	35.08	32.69	41.83	47.75
Change	-	107.43%	3.23%	-73.55%	71.26%	-6.83%	27.97%	14.15%
Free Cash Flow (FCF) ¹	-140.1	-284.1	-386.9	-345.5	-274.9	-263	-196.9	-96.63
Change	-	-102.75%	-36.22%	10.72%	20.41%	4.34%	25.13%	50.92%
Announcement Date	24/02/21	23/02/22	23/02/23	22/02/24	20/02/25	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Guardant Health, Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-29.71%	-104.04%	-110.98%	-77.36%	-54.06%	-22.15%	-12.65%	0.96%
EBIT Margin (%)	-88.92%	-110%	-121.1%	-100.14%	-60.02%	-41.74%	-29.64%	-16.28%
EBT Margin (%)	-85.76%	-102.89%	-145.36%	-84.9%	-58.87%	-39.28%	-27.85%	-14.79%
Net margin (%)	-88.51%	-108.57%	-145.61%	-85.02%	-59.05%	-39.59%	-28.13%	-14.51%
FCF margin (%)	-48.86%	-76.02%	-86.07%	-61.26%	-37.2%	-27.14%	-15.98%	-6.15%
FCF / Net Income (%)	55.2%	70.02%	59.11%	72.05%	63.01%	68.56%	56.81%	42.39%
Profitability
ROA	-15.69%	-18.13%	-34.32%	-28.23%	-26.67%	-19.6%	-18.67%	-13.37%
ROE	-24.21%	-41.75%	-185.65%	-438.12%	-	-	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-0.52x	-0.25x	-	-0.76x	-2.61x	-5.28x	35.56x
Debt / Free cash flow	-	-0.71x	-0.33x	-	-1.1x	-2.13x	-4.18x	-5.53x
Capital Intensity
CAPEX / Current Assets (%)	12.62%	20.08%	17.23%	3.63%	4.75%	3.37%	3.4%	3.04%
CAPEX / EBITDA (%)	-42.46%	-19.3%	-15.53%	-4.7%	-8.78%	-15.23%	-26.84%	317.86%
CAPEX / FCF (%)	-25.82%	-26.42%	-20.02%	-5.93%	-12.76%	-12.43%	-21.24%	-49.41%
Items per share
Cash flow per share ¹	-1.066	-2.063	-3.029	-2.902	-1.954	-1.534	-1.162	-
Change	-	-93.55%	-46.8%	4.19%	32.66%	21.49%	24.27%	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	12.96	6.338	0.5864	1.305	-1.126	-3.223	-4.107	-2.879
Change	-	-51.08%	-90.75%	122.46%	-186.33%	-186.15%	-27.45%	29.91%
EPS ¹	-2.6	-4	-6.41	-4.28	-3.56	-3.083	-2.776	-1.875
Change	-	-53.85%	-60.25%	33.23%	16.82%	13.4%	9.96%	32.48%
Nbr of stocks (in thousands)	99,972	101,656	102,436	121,380	123,555	128,839	128,839	128,839
Announcement Date	24/02/21	23/02/22	23/02/23	22/02/24	20/02/25	-	-	-